Literature DB >> 29715449

Superficial Parotidectomy Versus Partial Superficial Parotidectomy: A Comparison of Complication Rates, Operative Time, and Hospital Stay.

Ahmet Erdem Kilavuz1, Murat Songu2, Ercan Pinar3, Yilmaz Ozkul2, Sedat Ozturkcan2, Ibrahim Aladag4.   

Abstract

PURPOSE: The type and extent of surgery for benign parotid tumors are a subject of debate. We aimed to measure and compare hospital stay, operative time, and complication rates associated with superficial parotidectomy (SP) and partial superficial parotidectomy (PSP).
MATERIALS AND METHODS: This retrospective cohort study included all patients who underwent surgery for benign parotid gland tumors in our tertiary center between January 2006 and March 2014 and were followed up for at least 3 years. The predictor variable was the type of parotidectomy, and the main outcome parameters were operative time, hospital stay, and postoperative complications. The demographic characteristics (age and gender), clinical history, and preoperative findings were obtained from patient records. The Kolmogorov-Smirnov test, Mann-Whitney U test, and χ2 test were used to analyze the data. P < .05 was considered statistically significant.
RESULTS: The sample was composed of 321 patients (184 men and 137 women) with a mean age of 54.0 ± 14.7 years (range, 18 to 87 years). Of these, 190 underwent SP and 131 underwent PSP. Pleomorphic adenoma was the most common tumor (83 patients, 53%), followed by Warthin tumor (50 patients, 32%). The mean hospital stay was 6.7 ± 2.3 days in the SP group and 4.8 ± 2.4 days in the PSP group (P < .001). The mean operative times in the SP and PSP groups were 134.0 ± 24.6 and 92.1 ± 21.9 minutes, respectively (P < .001). The overall complication rates were 21.6% and 12.2% in the SP and PSP groups, respectively (P = .031). No tumor recurrence was observed in either group.
CONCLUSIONS: Compared with the SP group, the PSP group had shorter operative and hospital stay durations and fewer postoperative complications with a comparable recurrence rate. Therefore, PSP should be considered in suitable cases.
Copyright © 2018 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29715449     DOI: 10.1016/j.joms.2018.04.001

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

Review 1.  Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors.

Authors:  Georgios Psychogios; Christopher Bohr; Jannis Constantinidis; Martin Canis; Vincent Vander Poorten; Jan Plzak; Andreas Knopf; Christian Betz; Orlando Guntinas-Lichius; Johannes Zenk
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

Review 2.  LigaSure versus Conventional Parotidectomy: A Systematic Review and Meta-Analysis.

Authors:  Sonia Wei-Ting Chen; Li-Jen Hsin; Wan-Ni Lin; Yao-Te Tsai; Ming-Shao Tsai; Yi-Chan Lee
Journal:  Healthcare (Basel)       Date:  2022-04-11

3.  Reconstructive trends and complications following parotidectomy: incidence and predictors in 11,057 cases.

Authors:  Cory Donovan Bovenzi; Peter Ciolek; Meghan Crippen; Joseph M Curry; Howard Krein; Ryan Heffelfinger
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-11-19

4.  Posterior Belly of Digastric Muscle Transposition Flap in Preventing Frey's Syndrome after Superficial Parotidectomy- A Prospective Study.

Authors:  Srikant Patro; Narendra Nath Swain; Kailash Chandra Mohapatra; Haramohan Barik; Ashish Kumar Sahoo; Prasanjit Pattnayak
Journal:  Ann Maxillofac Surg       Date:  2022-02-01

5.  Long-term outcomes and quality of life following parotidectomy for benign disease.

Authors:  Michaela Plath; Matthias Sand; Carlo Cavaliere; Peter K Plinkert; Ingo Baumann; Karim Zaoui
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-06       Impact factor: 2.618

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.